Catheter ablation of right atrial ganglionated plexi to treat cardioinhibitory neurocardiogenic syncope: a long-term follow-up prospective study
Authors:
- 6 August 2020
- journal article
- research article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 61 (3) , 499-510
Abstract
Purpose Several reports have focused on biatrial ganglionated plexi (GP) transcatheter ablation to treat cardioinhibitory neurocardiogenic syncope (CNS). Considering that anatomical studies showed a significant number of GP in the right atrium (RA), we hypothesized that RA “cardioneuroablation” could be an effective treatment for CNS. Methods Eighteen consecutive patients (mean age: 36.9 ± 11.2 years) with severe CNS were submitted to transcatheter ablation of GPs in the RA alone using an anatomical approach. Head up tilt test evaluation was performed during the follow-up period at 6, 12, and 24 months and in case of significant symptoms, while heart rate variability parameters were evaluated at patients discharge at 1, 3, 6, 12, 24, and 36 months after ablation. Results At a mean follow-up of 34.1 ± 6.1 months, 3 (16.6%) patients experienced syncopal episodes and 5 patients (27.7%) only prodromal episodes. Syncopal and prodromal recurrences were significantly decreased both in overall population (P = 0.001) and in symptomatic patients after ablation (P = 0.003). Heart rate variability analysis showed the loss of autonomic balance secondary to a reincrease of sympathetic tone after the acute phase faster than vagal tone more evident at 12 months (LF/HF vs preablation, P < 0.001) and persistent until 24 months. Finally, a good correlation was observed between symptomatic events and the extension of RF lesions in supero-, middle-, and infero-posterior RA areas (r = 0.73, P = 0.03; r = 0.85, P = 0.02; r = 0.87, P = 0.004, respectively). Conclusions Cardioneuroablation in the RA can be considered safe and an effective technique to treat CNS episodes.Keywords
This publication has 34 references indexed in Scilit:
- Pacemaker Therapy in Patients With Neurally Mediated Syncope and Documented AsystoleCirculation, 2012
- Tilt testing and neurally mediated syncope: too many protocols for one condition or specific protocols for different situations?European Heart Journal, 2009
- The Expectation Effect and Cardiac Pacing for Refractory Vasovagal SyncopeThe American Journal of Medicine, 2007
- A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE)European Heart Journal, 2004
- Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal SyncopeJAMA, 2003
- Incidence and Prognosis of SyncopeNew England Journal of Medicine, 2002
- Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal SyncopeCirculation, 2001
- Dual-Chamber Pacing in the Treatment of Neurally Mediated Tilt-Positive Cardioinhibitory SyncopeCirculation, 2000
- The North American vasovagal pacemaker study (VPS)JACC, 1999
- The Clinical Spectrum of Neurocardiogenic SyncopeJournal of Cardiovascular Electrophysiology, 1995